Eugene, OR, United States of America

Christopher Langsdorf

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christopher Langsdorf: Innovator in Cell-Tracking Reagents

Introduction

Christopher Langsdorf is a notable inventor based in Eugene, OR (US). He has made significant contributions to the field of cell-tracking reagents, holding a total of 2 patents. His work focuses on developing innovative compounds and methods that enhance the tracking of cell proliferation, differentiation, and function.

Latest Patents

Langsdorf's latest patents include the development of 7-hydroxycoumarin-based cell-tracking reagents. These patents describe compounds, methods, and kits designed for long-term tracking of cell activities. The novel cell-tracking reagents are efficiently excitable with a 405-nm violet laser, providing bright fluorescence intensity, uniform cell staining, and good retention within cells. Additionally, these reagents exhibit low toxicity toward cells, making them valuable tools in biological research.

Career Highlights

Christopher Langsdorf is associated with Life Technologies Corporation, where he continues to advance his research in cell-tracking technologies. His work has been instrumental in improving methodologies for studying cellular processes, which are crucial for various applications in biomedical research.

Collaborations

Langsdorf has collaborated with notable colleagues, including Jixiang Liu and Hee Chol Kang. These partnerships have contributed to the development of innovative solutions in the field of cell tracking.

Conclusion

Christopher Langsdorf's contributions to the field of cell-tracking reagents highlight his role as an influential inventor. His innovative patents and collaborations continue to impact research methodologies in significant ways.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…